Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: A crossover design study of unilateral versus bilateral injection

Laryngoscope

Volumn 110, Issue 8, 2000, Pages 1366-1374

  Warrick, Paul ^a   Dromey, Christopher ^a   Irish, Jonathan C ^c   Durkin, Lisa ^a   Pakiam, Anthony ^b   Lang, Anthony ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Botulinum toxin; Essential tremor

Indexed keywords

BOTULINUM TOXIN;

ACOUSTICS; ADULT; AGED; AIRWAY RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033890804     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200008000-00028     Document Type: Article

References (40)

1. Organic voice tremor: A tremor of phonation
2. Essential tremor: Clinical correlates in 350 patients
3. Epidemiology of essential tremor
4. The relationship of essential tremor to other movement disorders: Report on 678 patients
5. Head, facial and voice tremor
6. Dysphonia due to tremor
7. An evaluation of laryngeal muscle activation in patients with vocal tremor
8. The nature of primary vocal tremor
9. How familial is familial tremor? The genetic epidemiology of essential tremor
10. Oscillatory properties of guinea pig inferior olivary neurones and their pharmacological modulation: An in-vitro study
11. A positron emission tomography study of essential tremor: Evidence for overactivity of cerebellar connections
12. Glucose metabolism in the brain of patients with essential tremor
13. Is there a relationship between Parkinson's disease and essential tremor?
14. Association between essential tremor and Parkinson's disease
15. Factors influencing the amplitude and frequency of essential tremor
16. Vocal tremor analysis with the vocal demodulator
17. Methazolamide for essential voice tremor
18. Essential voice tremor: Treatment with propranolol
19. Long-acting propranolol in essential tremor
20. Essential vocal tremor: Clinical characteristics and response to therapy
21. Spastic dysphonia and essential (voice) tremor treated with primidone
22. Treatment of essential tremor with methazolamide
23. Acute and chronic effects of botulinum toxin in the management of blepharospasm
24. Management of facial spasm with clostridium botulinum toxin, type A (Oculinum)
25. Oromandibular dystonia: Treatment of 96 patients with botulinum toxin type A
26. Botulinum toxin A for cranial-cervical dystonia: A double blind placebo controlled study
27. Limb dystonia: Treatment with botulinum toxin
28. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia
29. The evaluation and management of abductor laryngeal dystonia
30. Botulinum toxin in the treatment of tremors
31. Treatment of voice tremor with botulinum toxin injection
32. Responses of stutterers and vocal tremor patients to treatment with botulinum toxin
33. Botulinum toxin injection for adductor spasmodic dysphonia
34. A clinical method for estimating laryngeal airway resistance during vowel production
35. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia
36. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia
37. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia
38. A comparison of bilateral and unilateral botulinum toxin treatments for botulinum toxin treatments for spasmodic dysphonia
39. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: Acoustic and perceptual results
40. Botulinum toxin as a therapeutic agent